CARLOS JOSE
MATUTE ALMAU
UNIBERTSITATEKO KATEDRADUNA
Universitat de Barcelona
Barcelona, EspañaUniversitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2021
-
A multicentre, randomised, controlled trial of a combined clinical treatment for first-episode psychosis
International Journal of Environmental Research and Public Health, Vol. 18, Núm. 14
2020
-
N-Methyl-D-Aspartate Receptor Antibodies in Autoimmune Encephalopathy Alter Oligodendrocyte Function
Annals of Neurology, Vol. 87, Núm. 5, pp. 670-676
2017
2016
-
BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year
Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151
2015
2014
-
Differential neuroprotective effects of 5′-deoxy-5′- methylthioadenosine
PLoS ONE, Vol. 9, Núm. 3
2011
-
Amyloid β peptide oligomers directly activate NMDA receptors
Cell Calcium, Vol. 49, Núm. 3, pp. 184-190
-
Bax and calpain mediate excitotoxic oligodendrocyte death induced by activation of both AMPA and kainate receptors
Journal of Neuroscience, Vol. 31, Núm. 8, pp. 2996-3006
2007
-
Bax and calpain mediate excitotoxic oligodendrocyte death induced by activation of AMPA and kainate receptors
NEURON GLIA BIOLOGY
-
Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons
Neuroscience, Vol. 146, Núm. 1, pp. 350-365